← All companies

NKTP

Nok Therapeutics, Inc.

NKTP OTC Pharmaceutical Preparations EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

—

Net income (TTM) ⓘ

—

EPS (TTM) ⓘ

—

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

—

Cash ⓘ

—

Total assets ⓘ

—

Gross margin ⓘ

—

52-week range ⓘ

—

Recent SEC filings

34 most recent

Other filings

1-SA SEMIANNUAL REPORT PURSUANT TO REGULATION A Sep 28, 2026

1-U Item 9.1 Jul 15, 2026

1-U Item 7 Jun 3, 2026

D/A Item 06b May 1, 2026

D/A Item 06b May 1, 2026

1-K Apr 30, 2026

D/A Item 06b Apr 22, 2026

D/A Item 06b Apr 22, 2026

D/A Item 06b Apr 22, 2026

D Item 06b Mar 26, 2026

D Item 06b Oct 24, 2025

D Item 06b Oct 24, 2025

1-SA SEMIANNUAL REPORT PURSUANT TO REGULATION A Sep 30, 2025

1-K May 6, 2025

QUALIF Jan 3, 2025

CORRESP Dec 30, 2024

CORRESP Dec 23, 2024

1-A/A Dec 23, 2024

UPLOAD Dec 20, 2024

CORRESP Dec 17, 2024

1-A/A Dec 17, 2024

UPLOAD Dec 13, 2024

CORRESP Dec 9, 2024

1-A/A Dec 9, 2024

UPLOAD Dec 3, 2024

CORRESP Nov 26, 2024

1-A/A Nov 26, 2024

CORRESP Nov 25, 2024

1-A/A Nov 25, 2024

UPLOAD Nov 19, 2024

CORRESP Nov 7, 2024

1-A/A Nov 7, 2024

UPLOAD Oct 23, 2024

1-A Sep 26, 2024